Department of Pharmacy, Xiangtan Central Hospital, Hunan, China.
Department of Social Medicine and Health Management, Xiangya School of Public Health, Central South University, Changsha, Hunan, China.
BMC Pregnancy Childbirth. 2022 Apr 29;22(1):370. doi: 10.1186/s12884-022-04690-3.
Previous studies have shown that polycystic ovary syndrome is a predictor of gestational diabetes mellitus, but we do not know exactly how many polycystic ovary syndrome patients may develop gestational diabetes mellitus. Currently, the incidence of gestational diabetes mellitus among women with polycystic ovary syndrome varies greatly across studies, ranged from 4.12% to 59.50%. Besides, many factors have been found to be related to the incidence of gestational diabetes mellitus among women with polycystic ovary syndrome, but the results among different studies are not consistent. The possible causes of inconsistencies between the current estimates were unclear. This review aimed at exploring the pooled incidence of gestational diabetes mellitus among women with polycystic ovary syndrome, summarizing possible causes of the inconsistencies in the current estimates, try to provide a reference for prevention of gestational diabetes mellitus and polycystic ovary syndrome in the future.
Systematic searches of different databases (including EMBASE, Web of Science, MEDLINE, The Cochrane Library, CNKI and PubMed) were conducted for studies published until 31 May 2021. Statistical analyses were performed using R software, the pooled incidence of gestational diabetes mellitus among polycystic ovary syndrome patients was combined using random effects model. Cochrane's "Tool to Assess Risk of Bias in Cohort Studies" was used for quality assessment.
Twenty-two longitudinal studies were included. A total of 24,574 women with polycystic ovary syndrome were identified in the 22 articles, of which 4478 were reported with gestational diabetes mellitus. The pooled incidence of gestational diabetes mellitus among women with polycystic ovary syndrome was 20.64%, with a 95% CI of 14.64% to 28.30%. In the meta-regression model, several variables including age, area, quality score and sample size were suggested as significant sources of heterogeneity, accounted for 77.57% of the heterogeneity across studies.
Evidence in this review suggests that gestational diabetes mellitus were common among women with polycystic ovary syndrome. More research is needed to found effective interventions for preventing gestational diabetes mellitus among women with polycystic ovary syndrome.
既往研究表明多囊卵巢综合征是妊娠期糖尿病的预测因素,但我们尚不清楚究竟有多少多囊卵巢综合征患者会发展为妊娠期糖尿病。目前,多囊卵巢综合征患者中妊娠期糖尿病的发生率在不同研究中差异很大,范围为 4.12%至 59.50%。此外,已经发现许多因素与多囊卵巢综合征患者中妊娠期糖尿病的发生率有关,但不同研究的结果并不一致。目前估计结果不一致的可能原因尚不清楚。本综述旨在探讨多囊卵巢综合征患者中妊娠期糖尿病的累积发生率,总结目前估计结果不一致的可能原因,以期为未来多囊卵巢综合征和妊娠期糖尿病的预防提供参考。
系统检索了不同数据库(包括 EMBASE、Web of Science、MEDLINE、The Cochrane Library、CNKI 和 PubMed),检索时间截至 2021 年 5 月 31 日。使用 R 软件进行统计学分析,采用随机效应模型合并多囊卵巢综合征患者中妊娠期糖尿病的累积发生率。采用 Cochrane“队列研究偏倚风险评估工具”进行质量评估。
共纳入 22 项纵向研究。22 篇文章共纳入 24574 例多囊卵巢综合征患者,其中 4478 例报告患有妊娠期糖尿病。多囊卵巢综合征患者中妊娠期糖尿病的累积发生率为 20.64%,95%CI 为 14.64%至 28.30%。在荟萃回归模型中,年龄、地区、质量评分和样本量等几个变量被认为是异质性的重要来源,占研究间异质性的 77.57%。
本综述中的证据表明,妊娠期糖尿病在多囊卵巢综合征患者中较为常见。需要进一步研究以发现针对多囊卵巢综合征患者预防妊娠期糖尿病的有效干预措施。